Reply to Nagappa and Marimuthu.

Zhao, Juanjuan; Su, Yingying; Ge, Shengxiang; Zhang, Jun; Zhang, Zheng

Zhao, Juanjuan; Su, Yingying; Ge, Shengxiang; Zhang, Jun; Zhang, Zheng.

Zhao J; Institute of Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Guangdong Province, China.
Su Y; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health and School of Life Science, Xiamen University, Fujian, China.
Ge S; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health and School of Life Science, Xiamen University, Fujian, China.
Zhang J; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health and School of Life Science, Xiamen University, Fujian, China.
Zhang Z; Institute of Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Guangdong Province, China.

Clin Infect Dis ; 71(11): 3016-3017, 2020 12 31.

Article in English | MEDLINE | ID: covidwho-1205557

Subject(s)

COVID-19; SARS-CoV-2; Antibody Formation; Humans

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2020 Document Type: Article Affiliation country: Cid

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google